Antipodes appoints former Magellan Analyst

Boutique investment firm, Antipodes Partners, has announced the appointment of Aidan Kerr as an investment analyst, effective March 2018.

In this role, Kerr is responsible for covering the global healthcare sector.

Kerr was previously an equity analyst in the healthcare team at Magellan Financial Group and has also worked for AstraZeneca, Accenture and as a research scientist at the University of New South Wales.

He is joined at Antipodes Partners by Andrew Findlay, who has been appointed to lead the firm as managing director; Vinayak Muralidharan, who has been appointed as investment analyst; and Kieran Rabbitt, who joins as an investment specialist.

Commenting on the expanded team, founder and CIO, Jacob Mitchell said: "With strong growth in our business and an investment-led culture, we've become an employer of choice for talented investment professionals who want to further their career in global equities. I'm delighted with the calibre of our recent hires which take our investment team to 17 professionals, of which three are based in London."